Biodesix, Inc. (NASDAQ:BDSX) Q4 2025 Earnings Call Transcript February 26, 2026
Biodesix, Inc. beats earnings expectations. Reported EPS is $-0.49, expectations were $-1.05.
Operator: Good day, and thank you for standing by. Welcome to the Biodesix, Inc. Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. To ask a question during the session, you will need to...
